MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
320.46%
Quick Ratio
293.90%
Cash Ratio
78.23%
Debt to Asset Ratio
57.92%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Trade receivables, net
    • Others
Liabilities Breakdown
    • Additional paid-in-capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
292,726
227,033
198,693
295,694
Restricted cash
155
5,155
5,090
5,000
Marketable securities
546,027
585,738
784,866
814,055
Trade receivables, net
192,311
187,356
134,476
113,285
Inventory
99,391
112,070
74,841
69,317
Prepaid expenses and other current assets
68,570
64,955
47,804
49,329
Total current assets
1,199,180
1,182,307
1,245,770
1,346,680
Property and equipment, net
11,592
8,035
1,499
2,913
Intangible assets, net
7,187
7,284
7,381
7,477
Operating lease right-of-use assets
5,578
6,203
4,939
5,387
Other noncurrent assets
21,108
23,498
-
-
Total assets
1,244,645
1,227,327
1,259,589
1,362,457
Accounts payable
34,514
60,801
48,878
44,941
Accrued liabilities
338,656
275,761
260,392
345,382
Operating lease liabilities
1,034
1,697
1,018
1,083
Total current liabilities
374,204
338,259
310,288
391,406
Loan payable, net of discount
340,794
340,330
339,881
339,753
Operating lease liabilities, net of current portion
5,923
5,284
6,731
5,566
Total long term liabilities
346,717
345,614
346,612
345,319
Total liabilities
720,921
683,873
656,900
736,725
Common stock, par value 0.0001 per share authorized 200,000,000 shares at june30, 2026 and december31, 2025 23,093,974 and 22,842,073 shares issued and outstanding at june30, 2026 and december31, 2025, respectively
2
2
2
2
Additional paid-in-capital
2,765,710
2,727,227
2,692,280
2,656,553
Accumulated other comprehensive income
808
1,082
873
1,068
Accumulated deficit
-2,242,796
-2,184,857
-2,090,466
-2,031,891
Total stockholders equity
523,724
543,454
602,689
625,732
Total liabilities and stockholders equity
1,244,645
1,227,327
1,259,589
1,362,457
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$546,027K (-10.61%↓ Y/Y)Cash and cashequivalents$292,726K (57.22%↑ Y/Y)Trade receivables,net$192,311K (142.72%↑ Y/Y)Inventory$99,391K (56.53%↑ Y/Y)Prepaid expenses andother current assets$68,570K (17.01%↑ Y/Y)Restricted cash$155K (-96.90%↓ Y/Y)Total current assets$1,199,180K (19.52%↑ Y/Y)Other noncurrentassets$21,108K Property and equipment,net$11,592K (617.77%↑ Y/Y)Intangible assets, net$7,187K (58.03%↑ Y/Y)Operating leaseright-of-use assets$5,578K (-4.84%↓ Y/Y)Total assets$1,244,645K (22.58%↑ Y/Y)Total liabilities andstockholders equity$1,244,645K (22.58%↑ Y/Y)Total liabilities$720,921K (125.71%↑ Y/Y)Total stockholdersequity$523,724K (-24.75%↓ Y/Y)Accumulated deficit-$2,242,796K (-16.95%↓ Y/Y)Total currentliabilities$374,204K (90.43%↑ Y/Y)Total long termliabilities$346,717K (182.11%↑ Y/Y)Additionalpaid-in-capital$2,765,710K (5.86%↑ Y/Y)Accumulated othercomprehensive income$808K (-27.27%↓ Y/Y)Common stock, par value0.0001 per share...$2K (0.00%↑ Y/Y)Accrued liabilities$338,656K (115.05%↑ Y/Y)Accounts payable$34,514K (-9.11%↓ Y/Y)Operating leaseliabilities$1,034K (-1.43%↓ Y/Y)Loan payable, net ofdiscount$340,794K (187.89%↑ Y/Y)Operating leaseliabilities, net of current...$5,923K (30.92%↑ Y/Y)

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

MADRIGAL PHARMACEUTICALS, INC. (MDGL)